Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 gene

Drug Metabolism and Disposition

Volumn 43, Issue 1, 2015, Pages 93-99

  Canet, Mark J ^a   Merrell, Matthew D ^a   Harder, Bryan G ^a   Maher, Jonathan M ^b   Wu, Tongde ^a   Lickteig, Andrew J ^a   Jackson, Jonathan P ^a   Zhang, Donna D ^a   Yamamoto, Masayuki ^b   Cherrington, Nathan J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; DNA; NUCLEAR FACTOR; TRANSCRIPTION FACTOR NRF2; XENOBIOTIC AGENT; ANTIOXIDANT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 3; TRANSCRIPTION FACTOR;

ABCC3 GENE; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; GENE; GENETIC IDENTIFICATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; INTRON; MOLECULAR CLONING; OXIDATIVE STRESS; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; GENETICS; METABOLISM; TUMOR CELL LINE;

RODENTIA;

ANTIOXIDANT RESPONSE ELEMENTS; ANTIOXIDANTS; CELL LINE, TUMOR; HUMANS; INTRONS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NF-E2-RELATED FACTOR 2; TRANSCRIPTION FACTORS;

EID: 84919608289     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.114.060103     Document Type: Article

References (36)

1. Adachi T, Nakagawa H, Chung I, Hagiya Y, Hoshijima K, Noguchi N, Kuo MT, and Ishikawa T (2007) Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol 6:335-348.
2. Aleksunes LM and Klaassen CD (2012) Coordinated regulation of hepatic phase I and II drugmetabolizing genes and transporters using AhR-, CAR-, PXR-, PPARa-, and Nrf2-null mice. Drug Metab Dispos 40:1366-1379.
3. Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, and Manautou JE (2008) Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol 226:74-83.
4. Ananthanarayanan M, Li Y, Surapureddi S, Balasubramaniyan N, Ahn J, Goldstein JA, and Suchy FJ (2011) Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol 300:G771-G781.
5. Borst P, de Wolf C, and van de Wetering K (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453:661-673.
6. Hardwick RN, Fisher CD, Canet MJ, Scheffer GL, and Cherrington NJ (2011) Variations in ATPbinding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metab Dispos 39:2395-2402.
7. Huo H, Magro PG, Pietsch EC, Patel BB, and Scotto KW (2010) Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance. Cancer Res 70:8726-8735.
8. Ikeda H, Serria MS, Kakizaki I, Hatayama I, Satoh K, Tsuchida S, Muramatsu M, Nishi S, and Sakai M (2002) Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen. Biochem J 364:563-570.
9. Jaiswal AK (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36:1199-1207.
10. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, and Fardel O (2006) Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drugsensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756-1763.
11. Klaassen CD and Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1-96.
12. Levy N, Tatomer D, Herber CB, Zhao X, Tang H, Sargeant T, Ball LJ, Summers J, Speed TP, and Leitman DC (2008) Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene. Mol Endocrinol 22:287-303.
13. Mahaffey CM, Mahaffey NC, Holland W, Zhang H, Gandara DR, Mack PC, and Forman HJ (2012) Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma. J Thorac Oncol 7:34-39.
14. Mahaffey CM, Zhang H, Rinna A, Holland W, Mack PC, and Forman HJ (2009) Multidrugresistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. Free Radic Biol Med 46:1650-1657.
15. Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, and Klaassen CD (2008) Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 106:319-328.
16. Maher JM, Cheng X, Slitt AL, Dieter MZ, and Klaassen CD (2005) Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 33:956-962.
17. Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, and Chen Y, et al. (2007) Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46:1597-1610.
18. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, and Wasserman WW, et al. (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38:5718-5734.
19. Merrell MD, Augustine LM, Slitt AL, and Cherrington NJ (2008) Induction of drug metabolism enzymes and transporters by oltipraz in rats. J Biochem Mol Toxicol 22:128-135.
20. Nguyen T, Rushmore TH, and Pickett CB (1994) Transcriptional regulation of a rat liver glutathione S-transferase Ya subunit gene. Analysis of the antioxidant response element and its activation by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 269: 13656-13662.
21. Nies AT, König J, Pfannschmidt M, Klar E, Hofmann WJ, and Keppler D (2001) Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94:492-499.
22. Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Takeda K, and Utsunomiya H, et al. (2008) Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 295:G735-G747.
23. Ros JE, Libbrecht L, Geuken M, Jansen PL, and Roskams TA (2003) High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 200:553-560.
24. Sasaki H, Shitara M, Yokota K, Hikosaka Y, Moriyama S, Yano M, and Fujii Y (2012) MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas. Mol Med Rep 6:705-708.
25. Shen G and Kong AN (2009) Nrf2 plays an important role in coordinated regulation of phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30:345-355.
26. Shilatifard A (2008) Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20:341-348.
27. Slitt AL, Cherrington NJ, Maher JM, and Klaassen CD (2003) Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab Dispos 31:1176-1186.
28. Sun Y, Ng L, Lam W, Lo CK, Chan PT, Yuen YL, Wong PF, Tsang DS, Cheung WT, and Lee SS (2008) Identification and characterization of a novel mouse peroxisome proliferatoractivated receptor alpha-regulated and starvation-induced gene, Ppsig. Int J Biochem Cell Biol 40:1775-1791.
29. Tanaka Y, Aleksunes LM, Cui YJ, and Klaassen CD (2009) ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. Toxicol Sci 108:247-257.
30. Wang J, Zhang M, Zhang L, Cai H, Zhou S, Zhang J, and Wang Y (2010) Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J Surg Res 164:e99-e105.
31. Young LC, Campling BG, Cole SP, Deeley RG, and Gerlach JH (2001) Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 7:1798-1804.
32. Zella LA, Kim S, Shevde NK, and Pike JW (2006) Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol 20:1231-1247.
33. Zhang DD (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38: 769-789.
34. Zhang DD and Hannink M (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23:8137-8151.
35. Zheng R, Shen R, Goodman OB, Jr, and Nanus DM (2006) Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter. Mol Cell Endocrinol 259:10-21.
36. Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, and Trauner M (2003) Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38:717-727.